Empyema

by

Definition

  • Empyema is a condition where pus collects in the pleural cavity, the space between the lungs and the chest wall. This typically occurs due to an infection spreading from the lungs, leading to the accumulation of infected fluid that becomes encapsulated.

Types of Empyema

  1. Acute Empyema:-
    • Description:- Occurs rapidly after an infection, typically within days to weeks. It is often associated with bacterial pneumonia.
    • Rationale:- The infection quickly leads to the accumulation of pus as the body’s immune response tries to contain the bacteria, resulting in acute inflammation.
  2. Chronic Empyema:-
    • Description:- Develops over weeks to months and is characterized by thickened pleural membranes and fibrous septations within the pleural space.
    • Rationale:- The prolonged infection leads to persistent inflammation, causing the pleural membranes to thicken and scar tissue to form, making the condition more difficult to treat.
  3. Complicated Parapneumonic Effusion:-
    • Description:- A type of pleural effusion that becomes infected but not fully encapsulated. It is an intermediate stage before the development of empyema.
    • Rationale:- The presence of bacteria in the pleural fluid causes infection and inflammation, but the body’s immune response has not yet led to complete encapsulation of the pus.

Pathophysiology 

  1. Infection:-
    • Rationale:- The most common cause is bacterial pneumonia, where the infection spreads from the lungs to the pleural space, leading to an inflammatory response.
  2. Inflammatory Response:-
    • Rationale:- The immune system responds to the infection by sending white blood cells to the pleural space, which leads to the production of pus and fibrin deposits, causing the pleural membranes to thicken and adhere to each other.
  3. Encapsulation of Pus:-
    • Rationale:- As the condition progresses, the pus becomes encapsulated by fibrous tissue, leading to the formation of an organized empyema. This can restrict lung expansion and cause respiratory distress.

Causes 

  1. Bacterial Pneumonia:-
    • Rationale:- The most common cause, where bacteria such as Streptococcus pneumoniae or Staphylococcus aureus infect the pleura, leading to pus formation.
  2. Lung Abscess:-
    • Rationale:- An abscess in the lung can rupture into the pleural space, causing empyema.
  3. Trauma or Surgery:-
    • Rationale:- Injury to the chest or invasive procedures can introduce bacteria into the pleural space, leading to infection.
  4. Tuberculosis:-
    • Rationale:- Mycobacterium tuberculosis can spread to the pleura, causing chronic empyema.

Clinical Manifestations

  1. Fever and Chills:-
    • Rationale:- The body’s response to infection often includes fever as a way to fight off the bacteria.
  2. Chest Pain:-
    • Rationale:- Inflammation of the pleura and the accumulation of pus can cause sharp, pleuritic chest pain that worsens with deep breathing.
  3. Dyspnea (Shortness of Breath):-
    • Rationale:- The accumulation of fluid and pus in the pleural cavity compresses the lung, making it difficult to breathe.
  4. Cough:-
    • Rationale:- The infection may cause a persistent cough, which could be productive if the infection is also in the lungs.
  5. Decreased Breath Sounds:-
    • Rationale:- Fluid in the pleural space dampens the transmission of breath sounds, making them harder to hear during auscultation.

Diagnostic Tests 

  1. Chest X-ray:-
    • Rationale:- Helps identify fluid collection in the pleural space and can show the extent of the effusion.
  2. Ultrasound:-
    • Rationale:- Used to locate the exact position of the fluid and to guide thoracentesis (needle aspiration).
  3. CT Scan:-
    • Rationale:- Provides a detailed view of the pleural space, showing the extent of the empyema and any complications like loculated (compartmentalized) fluid collections.
  4. Pleural Fluid Analysis:-
    • Rationale:- Fluid obtained via thoracentesis is analyzed for its chemical composition, cell count, and the presence of bacteria to confirm the diagnosis of empyema.
  5. Blood Tests:-
    • Rationale:- Elevated white blood cell count and inflammatory markers (e.g., CRP, ESR) indicate an ongoing infection.

Management 

Non-Pharmacological Management

1. Thoracentesis:-
  • Type:- Diagnostic and therapeutic procedure.
  • Location:- Performed in the pleural space, typically at the bedside or in a procedure room under sterile conditions.
  • Size and Instrumentation:-
    • Needle Size:- A 20-22 gauge needle or a specially designed thoracentesis needle, usually 7-12 cm in length.
    • Catheter:- Sometimes, a catheter (6-8 French) is used to drain fluid over time.
    • Other Instruments:- Sterile gloves, antiseptic solution, local anesthetic (like lidocaine), syringe, sterile drape, collection container, and dressing supplies.
  • Procedure:-
    • Preparation:- Explain the procedure to the patient, obtain informed consent, and ensure all materials are sterile.
    • Position:- The patient is usually positioned sitting upright, leaning slightly forward with their arms resting on a table to widen the intercostal spaces.
    • Procedure:-
      • The clinician identifies the site (typically between the 7th and 9th intercostal spaces on the mid-axillary line) using ultrasound guidance to avoid injury to the lung or other organs.
      • The skin is cleansed with antiseptic, and local anesthesia is administered.
      • The needle is carefully inserted above the rib to avoid the neurovascular bundle located below each rib.
      • Once pleural fluid is accessed, it is either aspirated directly into a syringe or via a catheter into a collection bag.
    • Precautions:- Care is taken to avoid pneumothorax (air in the pleural space) and infection. Continuous monitoring of the patient’s vital signs is crucial.
  • Post-Procedure:- The site is dressed with a sterile bandage, and the patient is monitored for any immediate complications like pneumothorax or bleeding.
2. Chest Tube Insertion (Thoracostomy):-
  • Type:- Therapeutic procedure for continuous drainage.
  • Location:- Pleural space, typically between the 4th and 5th intercostal spaces on the mid-axillary line.
  • Size and Instrumentation:-
    • Tube Size:- For adults, typically a 24-36 French chest tube is used; smaller sizes may be used for children or smaller collections.
    • Other Instruments:- Sterile gloves, antiseptic solution, scalpel, forceps, suture materials, chest tube drainage system, and dressing supplies.
  • Procedure:-
    • Preparation:- Obtain informed consent, and ensure the patient is prepared and positioned correctly.
    • Position:- The patient lies supine or slightly rotated with the arm on the affected side raised above the head to expose the chest area.
    • Procedure:-
      • The site is identified and marked (typically between the 4th and 5th ribs, mid-axillary line).
      • The area is cleaned with an antiseptic, and local anesthesia is applied.
      • A small incision is made at the site, and a blunt dissection is performed with forceps to create a path into the pleural space.
      • The chest tube is then inserted and directed posteriorly and superiorly to ensure proper placement in the pleural space.
      • The tube is connected to a drainage system, and secure sutures are placed around the insertion site.
      • A sterile dressing is applied.
    • Precautions:- Continuous monitoring for signs of infection, tube dislodgment, or blockage is essential. Proper securing of the tube prevents accidental dislodgment.
  • Post-Procedure:- The patient is monitored closely for adequate drainage, lung re-expansion, and any signs of complications such as infection or re-accumulation of fluid.
3. Fibrinolytic Therapy:-
  • Type:- Non-surgical procedure for enhancing drainage.
  • Location:- Administered directly into the pleural space via the chest tube.
  • Size and Instrumentation:-
    • Agents Used:- Enzymes like streptokinase or urokinase.
    • Other Instruments:- Syringes for drug administration, chest tube, drainage system, and sterile dressing.
  • Procedure:-
    • Preparation:- Ensure the patient understands the procedure and obtains consent.
    • Position:- The patient can remain in the same position as for chest tube placement, usually supine or slightly rotated.
    • Procedure:-
      • The fibrinolytic agent is prepared and drawn into a syringe.
      • The chest tube is clamped temporarily to prevent outflow during administration.
      • The agent is injected slowly into the chest tube and allowed to remain in the pleural space for a specified period (usually 1-4 hours) to break down the fibrin.
      • After the period, the chest tube is unclamped to allow the drainage of liquefied pus.
    • Precautions:- Monitoring for allergic reactions or bleeding is critical. The patient should be closely observed during and after the procedure.
  • Post-Procedure:- Ensure effective drainage of the pleural fluid, and monitor the patient’s respiratory status and chest tube function.

Pharmacological Management 

1. Antibiotic Therapy:-
  • Type:- Broad-spectrum and targeted antibiotic therapy.
  • Indication:- To eliminate the bacterial infection responsible for the empyema.
  • Choice of Antibiotics:-
    • Initial Broad-Spectrum Antibiotics:-
      • Common Agents:-
        • Penicillin/Beta-lactamase inhibitors (e.g., Piperacillin-Tazobactam):- Effective against a wide range of bacteria, including anaerobes.
        • Cephalosporins (e.g., Ceftriaxone, Cefotaxime):- Broad-spectrum coverage, often used as first-line therapy.
        • Carbapenems (e.g., Meropenem, Imipenem):- Used for resistant organisms or severe infections.
        • Vancomycin or Linezolid:- If methicillin-resistant Staphylococcus aureus (MRSA) is suspected.
    • Targeted Therapy:-
      • After obtaining culture and sensitivity results from pleural fluid, the therapy is adjusted to target the specific causative bacteria. For instance:
        • Streptococcus pneumoniae:- Penicillin or third-generation cephalosporins.
        • Staphylococcus aureus:- Oxacillin or vancomycin if MRSA.
        • Anaerobic bacteria:- Metronidazole or clindamycin may be added.
  • Administration:-
    • Route:- Typically intravenous (IV) for more severe cases, followed by oral therapy as the patient improves.
    • Duration:- Typically 2-4 weeks, depending on the severity of the infection and the patient’s response to treatment.
  • Rationale:- Early and appropriate antibiotic therapy is critical in controlling the infection, reducing the duration of illness, and preventing complications such as the progression to chronic empyema.
2. Anti-inflammatory Agents:-
  • Type:- Non-steroidal anti-inflammatory drugs (NSAIDs).
  • Indication:- To reduce pleuritic pain and inflammation associated with empyema.
  • Common Agents:-
    • Ibuprofen:- Often used to manage pain and reduce inflammation.
    • Naproxen:- Another option for reducing pain and inflammation.
  • Administration:-
    • Route:- Oral or intravenous, depending on the severity of the symptoms.
    • Dose:- Adjusted according to the patient’s pain level and response.
  • Rationale:- Reducing inflammation helps alleviate chest pain, improves breathing, and enhances the patient’s overall comfort.
3. Analgesics:-
  • Type:- Pain relief medication.
  • Indication:- To manage the pain associated with chest tube placement, thoracentesis, or the condition itself.
  • Common Agents:-
    • Acetaminophen (Paracetamol):- Used for mild to moderate pain.
    • Opioids (e.g., Morphine, Fentanyl):- Used for severe pain, particularly post-surgical or when chest tubes are in place.
  • Administration:-
    • Route:- Oral, intravenous, or via patient-controlled analgesia (PCA) pumps for more severe cases.
    • Dose:- Tailored to the patient’s pain level and medical condition.
  • Rationale:- Effective pain management is crucial for patient comfort, adherence to breathing exercises, and overall recovery. Poorly controlled pain can lead to shallow breathing, atelectasis, and further complications.
4. Antipyretics:-
  • Type:- Fever-reducing medications.
  • Indication:- To control fever, which is common in infections like empyema.
  • Common Agents:-
    • Acetaminophen (Paracetamol):- Commonly used to reduce fever.
    • Ibuprofen:- Dual action as an antipyretic and anti-inflammatory.
  • Administration:-
    • Route:- Oral or intravenous.
    • Dose:- Given according to the patient’s age, weight, and fever severity.
  • Rationale:- Managing fever is important for patient comfort and to reduce metabolic demands on the body, especially in severely ill patients.

Surgical Management

1. Surgery (Decortication):-
  • Type:- Open or thoracoscopic surgical procedure.
  • Location:- Performed in the operating room, focusing on the pleural space and lung surface.
  • Size and Instrumentation:-
    • Surgical Approach:- Open thoracotomy or video-assisted thoracoscopic surgery (VATS).
    • Instruments:- Surgical instruments include a scalpel, forceps, rib spreader, electrocautery, suction devices, thoracoscope (for VATS), and suturing materials.
  • Procedure:-
    • Preparation:- Preoperative imaging (like CT scans) is performed to assess the extent of empyema. The patient is fully prepared for surgery under general anesthesia.
    • Position:- The patient is positioned laterally on the operating table, with the affected side facing up.
    • Procedure:-
      • An incision is made on the chest wall, either a large one for open thoracotomy or several small ones for VATS.
      • The pleura is carefully dissected, and the thickened fibrous tissue is removed from the lung surface.
      • The trapped pus and any necrotic tissue are also removed to allow the lung to re-expand fully.
      • The chest cavity is irrigated with saline to remove any residual debris.
      • Chest tubes are placed to drain the pleural space postoperatively.
      • The incision is closed, and a sterile dressing is applied.

Nursing Care

  1. Monitoring Vital Signs:-
    • Rationale:- Regular monitoring helps detect early signs of complications like sepsis or respiratory distress.
  2. Pain Management:-
    • Rationale:- Administer analgesics to manage pleuritic chest pain and improve patient comfort.
  3. Positioning:-
    • Rationale:- Position the patient in a semi-Fowler’s position to facilitate breathing and drainage of the pleural fluid.
  4. Oxygen Therapy:-
    • Rationale:- Provide supplemental oxygen to maintain adequate oxygenation, especially if the patient is experiencing dyspnea.
  5. Education:-
    • Rationale:- Educate the patient and family about the condition, treatment plan, and the importance of completing the full course of antibiotics.

Complications 

  1. Fibrothorax:-
    • Rationale:- Chronic empyema can lead to the formation of a thick, fibrous layer around the lung, restricting lung expansion.
  2. Sepsis:-
    • Rationale:- If the infection spreads into the bloodstream, it can lead to sepsis, a life-threatening condition requiring immediate treatment.
  3. Bronchopleural Fistula:-
    • Rationale:- An abnormal connection may form between the bronchial tubes and the pleural cavity, causing persistent air leakage and infection.
  4. Respiratory Failure:-
    • Rationale:- Severe cases of empyema can compromise lung function, leading to respiratory failure if not treated promptly.

Leave a Comment